Journal
NATURE MEDICINE
Volume 19, Issue 6, Pages 676-677Publisher
NATURE PORTFOLIO
DOI: 10.1038/nm.3233
Keywords
-
Ask authors/readers for more resources
Cancers are known to evolve in response to therapy, which may result in drug resistance. However, following this process in patients is challenging, as repeated biopsies of tumor tissue involves invasive procedures and tumor heterogeneity confounds interpretation of analyses. A recent study by Murtaza et al. 1 describes an approach to trace the genomic evolution of tumors in response to therapy by sampling circulating cell-free tumor DNA (ctDNA) from patient plasma at different time points during treatment. This strategy allowed the authors to detect mutations associated with therapy resistance. We asked three experts to comment on this study and its implications for studying and treating tumors in the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available